Treatment with aromatase inhibitors and markers of cardiovascular disease.

about

Breast cancer treatment-induced cardiotoxicity.

P2860

Q39428826-10AD6D2B-CDE2-4383-8128-1FFC743148D4

P2860

Treatment with aromatase inhibitors and markers of cardiovascular disease.

Item

http://www.wikidata.org/entity/Q39356527

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Treatment with aromatase inhibitors and markers of cardiovascular disease.

@en

Treatment with aromatase inhibitors and markers of cardiovascular disease.

@nl

type

Item

label

Treatment with aromatase inhibitors and markers of cardiovascular disease.

@en

Treatment with aromatase inhibitors and markers of cardiovascular disease.

@nl

prefLabel

Treatment with aromatase inhibitors and markers of cardiovascular disease.

@en

Treatment with aromatase inhibitors and markers of cardiovascular disease.

@nl

P1476

Treatment with aromatase inhibitors and markers of cardiovascular disease

@en

P2093

Alessia D'Alonzo

http://www.w3.org/2001/XMLSchema#string

Claudia Bighin

http://www.w3.org/2001/XMLSchema#string

Debora Musio

http://www.w3.org/2001/XMLSchema#string

Domenico Palombo

http://www.w3.org/2001/XMLSchema#string

Francesca Poggio

http://www.w3.org/2001/XMLSchema#string

Maria Cecilia Perfumo

http://www.w3.org/2001/XMLSchema#string

Paolo Bruzzi

http://www.w3.org/2001/XMLSchema#string

Sara Giraudi

http://www.w3.org/2001/XMLSchema#string

Stefania Vecchio

http://www.w3.org/2001/XMLSchema#string

Valerio Gazzola

http://www.w3.org/2001/XMLSchema#string

P2860

Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

Prevalence of asymptomatic carotid artery stenosis in the general population: an individual participant data meta-analysis

The protective effects of estrogen on the cardiovascular system.

Effects of SERMs on important indicators of cardiovascular health: lipoproteins, hemostatic factors, and endothelial function.

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

Postmenopausal hormone therapy and the risks of coronary heart disease, breast cancer, and stroke.

Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update

Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial.

Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials.

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

P2888

s10549-016-3985-7

P304

261-267

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10549-016-3985-7

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

160

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-09-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27663435

http://www.w3.org/2001/XMLSchema#string

Treatment with aromatase inhibitors and markers of cardiovascular disease.

about

P2860

P2860

Treatment with aromatase inhibitors and markers of cardiovascular disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698